clinical trial · NCT07566975
Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study
Neuro-Ophthalmology of Texas·—·recruiting·n = 50
Dry EyeCyclosporine ophthalmic solution 0.1%
brief summary
patients from a Neuro Ophthalmology who have dry eye, some of which have neurotrophic keratitis are being analyzed after treatment with Vevye
started
Mar 31, 2026
primary completion
Nov 30, 2026
completion
Nov 30, 2026
last updated
May 5, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol